Chc Healthcare Group · TWSE:4164
Chc Healthcare — Investor Presentation (June 2025)
33 slides from Chc Healthcare's investor presentation, Jun 23, 2025
Slide 1: CHC Healthcare Group (4164) 2025 Investor Presentation
74 Se FE Be (4164) 2025 FE R—REARAS CSC axe
Slide 2: CHC Disclaimer
CSC z#+8 WHR AARE RR ARI AIRASI (LA PR REE Pitt > AICPA Bate RGUSRSEXSA > AREBHBSRA CSAS IEE + SHEE +s OER IEE > PEAT AR BAT -ZESPAERHE TR ° AXMPASRA EMEA CARAS > MRLBRMRERREBARA > Pins AAVA HRA > SORA ERAS HRA AA PM ERS BEE © ASSCHP RD AEE eS UME RR > Slee BAIR AS PAA ee BS SI AOR Ee SES RD + SPER
Slide 3: CNC a#t8
CNC a#t8
Slide 4: CNC a#t8
CNC a#t8
Slide 5: Company profile
• • 4164 • 2009 11 27 ( 1977 ) • • • • 1,846,488,710 • 2012 10 24
Slide 6: Elekta and company history
CNC a#t8 eat HERS 70S EB ETERS JARS ake RERERAD RABE 201755 199755 197755. SADR Sa SPUlaHe SS BER SAr< UBS SRR HRSWER EERIE A tH BI SF HX OR ES SE HE i i HK CLUS SRAM K RSIS SE SHAGEEE - ERISA - RASA AS SAO MTR HAR SOS AWA Hee aS Peae Elekta {ugree eae (oO) RAR I
Slide 7: CHC business overview
CSC ae28 Ete 7 hd BAH EARS ED RRAR SE aici)
Slide 8: Partner brands and customers
CNC a#t8 BS] Bem A a Tas ne fh A SP Maes HARES A ARF} ES 4 — re s G 3 aoa AIA EBER “a @ MICROSYSTEMS BRON vcs * BVI Piw IMRIS VUno Bd «<PAstiland -ROWNJUN ELEKTA Comp: ALBOMED ” ECOLAB CAScINATIONS Eanes Qereererne “plasmapp (Bmicrorex = HYC-RAD Klarity [Ec ) Swissray"=* Weis medica
Slide 9: CHC business
CNC ae28 BAU ARS Bate eS She RA Ate BSR ae ERAS DEAR a FS fH PR Aa LRM — well _ —_—
Slide 10: CHC
CSC a##8 SACS Eke - ERR wiaw & “2 j 2 “— Bes - Ed eave ng Pha ale r \ = A ee 4 i. gr t a” K y 3 Twa : BAH a/R - Deru meRRR == cs 4 re \ aa map OS anther = ey a i oo aco
Slide 11: CHC Sustainability
CSC a##8 we Ay cr HE al eH ial Bs] ma Se SUSTAINABILITY Ty) 30% of energy savings | BER
Slide 12: CNC a#t8
CNC a#t8
Slide 13: Revenue
( ) 5,000,000 3,877,137 4,000,000 3,600,574 2,974,352 3,000,000 2,554,911 2,439,564 2,000,000 1,556,294 1,252,042 1,000,000 - 2020 2021 2022 2023 2024 2024 1~5 2025 1~5 ( ) ( )
Slide 14: Operating results
CNC a#t8 ORE BEAR 9 MBA one SR
Slide 15: EBITDA
EBITDA ( ) ( ) 1,500,000 5 1,231,233 1,200,000 4 1,001,839 1,042,109 970,340 944,553 900,000 3 2.53 2.43 2.55 2.21 600,000 2 1.01 300,000 185,829 207,456 1 0.01 0.05 0 0 362,912 380,282 388,650 182,577 1,378 3,544 425,238 2020 2021 2022 2023 2024 2024 2025
Slide 16: Dividends
( ) 2.5 160% 140% ( ) ( ) 2 120% 2020 2.01 2.53 79% 1.5 100% 2021 2.011 2.43 83% 80% 1 60% 2022 2.01 2.21 91% 2023 2.01 2.55 79% 40% 0.5 150% 20% 2024 1.51 1.01 0 0% 2020 2021 2022 2023 2024
Slide 17: CNC a#t8
CNC a#t8
Slide 18: Elekta
CNC a#t8 HE tS SER - Elekta SER ARNE @Elekta —
Slide 19: Elekta
CSC a##8 pat HE ts Eee - Elekta (2th Be Ae DE BS Opes So) Elekta Elekta Unity
Slide 20: IBA
- IBA 40+% MARKET SHARE 75+ PROTON CENTERS 130,000+ PATIENTS IN PROTON THERAPY POWERED BY IBA TREATED ON IBA EQUIPMENT
Slide 21: Baxter
CNC a#t8 ERR ER - BaxteriE XA FiRRAR Baxter es |i (IVIL T (TU TTUHTTTT TTT]
Slide 22: BVI
CSC a##8 (Ein em - BVI= EAE TERICA Lk Gas se BVI @evi y FINEVISION HP @ OL ) | GFY @evi Market Leading Portfolio of FReySON aie Ophthalmic Surgical Devices
Slide 23: CHC milestones
CNC aet8 ha fe RES - IS iets 120 100 80 Rl puRHRM 60 20 5 a PAR PILAR FBS 2008 2012 2016 2020 20245
Slide 24: Irradiation process steps
CNC a#t8 aoe - ARS nts ae ie! STEP STEP STEP 01 02 03 04 05 06 07 Pepe rd sen © sane @Q@ ore Q@ exec QO we @® seu @® enue (E-Beam & X-Ray) .-..) = — ig. [} =e wA ee a” 2 STEP ‘STEP ‘STEP ‘STEP STEP STEP STEP 01 02 03 04 05 06 07 =] &% 5 ape oes > ~ > | nx > & > |=} > > 1@ RS GS tm > |G Ep ? 0 Sa Ram
Slide 25: ISO certifications
- ISO 9001 ISO 13485 ISO / IEC 17025
Slide 26: CNC a#t8
CNC a#t8
Slide 27: Elekta Evo
Elekta Evo Adapt at your rhythm The only CT-Linac that uniquely evolves on your terms and offers everything from the everyday to the extraordinary.
Slide 28: Neutron Therapeutics
CSC a##8 5 | EWA HRIEIS I - Neutron Therapeutics *% neutron ‘€therapeutics
Slide 29: Neutron Therapeutics
- Neutron Therapeutics 2025年5月美國Neutron Therapeutics 於芬蘭赫爾辛基大學醫院(HUS)使用加 速器式BNCT進行臨床治療
Slide 30: Neutron Therapeutics
CSC a##8 wu i = a i 7472 - Neutron Therapeutics tal neutron S therapeutics 2.6 MV 30mA, PROTON ACCELERATOR INFUSION OF THE BORON-10 he CARRYING DRUG POSTIONING
Slide 31: Irradiation application fields
• 消滅微生物 • 消滅細菌 • 抑制食材發芽 食材 醫療 • 確保無菌 • 降低感染風險 • 延長食品保鮮期 應用 領域 • 半導體切換效率提升 • 輻射交聯聚合物 • 材料改性 材料 其他 • 航太材料耐受性測試 • 寶石顏色增強 • 強化複合材料 • 郵政郵件淨化…
Slide 32: RARREX
CNC a#t8 RARREX abs Bees FRR RE (410038) {ETE TUS (300K) BEBE (A100)
Slide 33: Thank you!
Thank you! www.chcg.com Copyright © 2019 CHC Limited. All rights reserved.
CHC Healthcare Group — Investor Presentation (June 2025) on 6ix